Inflammatory effects of peritoneal dialysis: Evidence of systemic monocyte activation

Kidney International

Volumn 49, Issue 2, 1996, Pages 506-511

  Libetta, Carmelo ^b   De Nicola, Luca ^b   Rampino, Teresa ^b   De Simone, Walter ^b   Memoli, Bruno ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE PHASE PROTEIN; AMYLOID A PROTEIN; BETA 2 MICROGLOBULIN; INTERLEUKIN 6;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; HEMODIALYSIS PATIENT; HUMAN; INFLAMMATION; LEUKOCYTE ACTIVATION; MONOCYTE; PERIPHERAL LYMPHOCYTE; PERITONEAL DIALYSIS; PRIORITY JOURNAL;

EID: 0030040440     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1038/ki.1996.72     Document Type: Article

References (46)

1. HAKIM RM, FEARON DT, LAZARUS JM: Biocompatibility of dialysis membranes: Effects of chronic complement activation. Kidney Int 26:194-200, 1984
2. GEJYO F, HOMMA N, ARAKAWA KM: Carpal tunnel syndrome and β2-microglobulin related amyloidosis in chronic hemodialysis patients. Blood Purif 6:125-131, 1988
3. FENVES AZ, EMMETT M, WHITE MG, GREENWAY G, MICHAELS DB: Carpal tunnel syndrome with cystic hone lesions secondary to amyloidosis in chronic hemodialysis patients. Am J Kidney Dis 2:130-134, 1986
4. ZINGRAFF J, BEYNE P, URENA P, UZAN M, MAN NK, DESCAMPSLATSCHA B, DRUEKE T: Influence of hemodialysis membrane on β2-microglobulin kinetics. Nephrol Dial Transplant 3:284-290, 1988
5. ZAOUI PF, STONE WJ, HAKIM RM: Effects of dialysis membranes on beta-2-microglobulin production and cellular expression. Kidney Int 38:962-968, 1990
6. VAN YPERSELE DE STRIHOU C, JADOUL M, MALGHEM J, MALDAGUE B, JAMART J: Effect of dialysis membrane and patient's age on signs of dialysis-related amyloidosis. Kidney Int 39:1012-1019, 1991
7. HENDERSON LW, KOCH KM, DINARELLO CA, SHALDON S: Hemodialysis hypotension: The interleukin hypotesis. Blood Purif 1:3-8, 1983
8. LUGER A, KOVARIK J, STUMMVOLL HK, URBANSKA A, LUGER TA: Blood-membrane interaction in hemodialysis leads to increased cytokine production. Kidney Int 32:84-88, 1987
9. LONNEMANN G, VAN DER MEER JWM, CANNON JG, DINARELLO C, KOCH KM, GRANOLLERAS C, DESCHODT G, SHALDON S: Induction of tumor necrosis factor during extracorporeal blood purification. N Engl J Med 317:963-964, 1987
10. HAEFFNER-CAVAILLON N, CAVAILLON JM, CIANCIONI C, BACLE F, DELONS S, KAZATCHKINE MD: In vivo induction of interleukin-1 during hemodialysis. Kidney Int 35:1212-1218, 1989
11. HERBELIN A, URENA P, NGUYEN AT, ZINGRAFF J, DESCAMPSLATSCHA B: Elevated circulating levels of IL-6 in patients with chronic renal failure. Kidney Int 39:954-960, 1991
12. KRANE SM, GOLDRING MB: Potential role for interleukin 1 in fibrosis associated with chronic ambulatory peritoneal dialysis. Blood Purif 16:173-177, 1988
13. DAVIES SJ, SUASSUNA J, OGG CS, CAMERON SJ: Activation of immunocompetent cells in the peritoneum of patients treated with CAPD. Kidney Int 36:661-668, 1989
14. BOS HJ, SRUIJK DG, TUK CW, DE VELD JC, HELERHORST TJM, HOEFSMIT ECM, ARISZ L, BEELEN RHJ: Peritoneal dialysis induces a local sterile inflammatory state and the mesothelial cells in the effluent are related to the bacterial peritonitis incidence. Nephron 59:508-509, 1991
15. BETJES MGH, TUK CW, STRUIJK DG, KREDIET RT, ARISZ L, HOEFSMIT ECM, BEELEN RHJ: Immuno-effector characteristics of peritoneal cells during CAPD treatment: A longitudinal study. Kidney Int 43:641-648, 1993
16. BALLARDIE FW, KERR DN, TENNET G, PEPYS MG: Hemodialysis versus CAPD: Equal predisposition to amyloidosis? Lancet 8491:795-796, 1986
17. BENZ RL, SIEGFRIED JW, TEEMAN BP: Carpal tunnel syndrome in dialysis patients: Comparison between continuous ambulatory peritoneal dialysis and hemodialysis population. Am J Kidney Dis 11:473-476, 1988
18. MEMOLI B, LIBETTA C, RAMPINO T, DAL CANTON A, CONTE G, SCALA G, RUOCCO MR, ANDREUCCI VE: Hemodialysis related induction of interleukin-6 production by peripheral blood mononuclear cells. Kidney Int 42:320-326, 1992
19. RAMADORI G, VAN DAMME J, RIEDER H, MEYER ZUM BUSCHENFELDE K-H: Interleukin 6, the third mediator of acute-phase reaction, modulates hepatic protein synthesis in human and mouse. Comparison with interleukin 1 and tumor necrosis factor. Eur J Immunol 18:1259-1260, 1988
20. MARINKOVIC S, JAHREIS GP, WONG GG, BAUMANN H: IL-6 modulates the syntesis of a specific set of acute phase plasma proteins in vivo. J Immunol 142:808-812, 1988
21. GAULDIE J, NORTHEMANN W, FEY GH: IL-6 functions as an exocrine hormone in inflammation. J Immunol 144:3804-3808, 1990
22. BLUMBERG A, BURGI W: Behaviour of β2-M in patients with chronic renal failure undergoing hemodialysis, hemodiafiltration and continuous ambulatory peritoneal dialysis (CAPD). Clin Nephrol 27:245-249, 1987
23. GANAPATHI MK, MAY LT, SCHULTZ D, BRABENEC A, WEINSTEIN J, SEHGAL PB, KUSHNER I: Role of interleukin-6 in regulating synthesis of C-reactive protein and serum amyloid A in human hepatoma cell lines. Biophys Res Comm 157:271-277, 1988
24. RYGG M, NORDSTOGA K, HUSBY G, MARHAUG G: Expression of serum amyloid A genes in mink during induction of inflammation and amyloidosis. Biochim Biophys Acta 1216:402-408, 1993
25. DAUGIRDAS JT: Second generation logarithmic estimates of single-pool variable volume Kt/V: An analysis of error. J Am Soc Nephrol 4:1205-1213, 1993
26. WATSON PE, WATSON ID, BATT RD, PHIL D: Total body water volumes for adult males and females estimated from simple anthropometric measurements. Am J Clin Nutr 33:27-39, 1980
27. RAMPINO T, LIBETTA C, PALUMBO G, MEMOLI B, DAL CANTON A: Interleukin-6 production induced in peripheral blood mononuclear cells by a serum factor from IgA nephropathy patients is inhibited in vitro by specific sugars. Nephrol Dial Transplant 9:1560-1563, 1994
28. KIMMEL PL, PHILLIPS TM, PHILLIPS E, BOSCH JP: Effect of renal replacement therapy on cellular cytokine production in patients with renal disease. Kidney Int 38:129-135, 1990
29. LONNEMAN G, KOCH KM, SHALDON S, DINARELLO CA: Studies on the ability of hemodialysis membranes to induce, bind, and clear human interleukin 1. J Lab Clin Med 112:76-86, 1988
30. LAUDE-SHARP M, CAROFF M, SIMARD L, PUSINERI C, KAZATCHKINE MD, HAEFFNER-CAVAILLON N: Induction of IL-1 during hemodialysis: Transmembrane passage of intact endotoxin (LPS). Kidney Int 38: 1089-1094, 1990
31. GOLDMAN M, VANDENADEELE P, MOULART J, AMRAOUI Z, ABRAMOWICS D, NORTIER J, VANHERWEGHEM G-L, FIARS W: Intraperitoneal secretion of interleukin-6 during Continuous Ambulatory Peritoneal Dialysis. Nephron 56:277-280, 1990
32. TOPLEY N, JÖRRES A, LUTTMANN W, PETERSEN MM, JANINE LANG M, THIERAUCH K-H, MULLER C, COLES GA, DAVIS M, WILLIAMS JD: Human peritoneal mesothelial cells synthesize interleukin-6: Induction by IL-1β and TNFα. Kidney Int 43:226-233, 1993
33. ZAOUI P, HAKIM RM: The effects of the dialysis membrane on cytokine release. J Am Soc Nephrol 4:1711-1718, 1994
34. SHUSTER J, GOLD P, POULIK MD: β2-M levels in cancerous and other disease states. Clin Chim Act 67:307-313, 1976
35. KARLSSON FA, WIBELL L, ERVIN PE: β2-microglobulin in clinical medicine. Scan J Cin Lab Invest 40:S27-S37, 1980
36. WALTERS MT, STEVENSON FK, GOSWAMI R, SMITH JL, CAWLEY MID: Comparison of serum and synovial fluid concentrations of β2-microglobulin and C-reactive protein in relation to clinical disease activity and synovial inflammation in rheumatoid arthritis. Ann Rheum Dis 48:905-911, 1989
37. KIN K, KASAHARA T, ITON Y: β2-microglobulin production by highly purified human T and B lymphocytes in cell cultures stimulated with various mitogens. Immunology 36:47-54, 1979
38. RAMADORI G, MITSCH A, RIEDER H, MEYER ZUM BUSCHENFELDE KH: Alfa and gamma-interferon hut not interleukin-1 modulate synthesis and secretion of β2-microglobulin by hepatocytes. Eur J Clin Invest 18:343-351, 1988
39. NACHBAUR K, TROPPMAIR J, BIELING P, KOTLAN B, KONIG P, HUBER CH: Cytokines in the control of β2-microglobulin release. I. In vitro studies on various hematopoietic cells. Immunobiol 177:55-65, 1988
40. NACHBAUR K, TROPPMAIR J, KOTLAN B, KONIG P, AULITZKY W, BIELING P, HUBER CH: Cytokines in the control of β2-microglobulin release. II. In vitro studies on various hematopoietic cells. Immunobiol 177:66-75, 1988
41. PEREIRA BJG, SHAPIRO L, KING AJ, FALAGAS ME, STROM JA, DINARELLO CA: Plasma levels of IL-1β, TNFα and their specific inhibitors in undialyzed chronic renal failure, CAPD and hemodialysis patients. Kidney Int 45:890-896, 1994
42. WIESLANDER AP, NORDIN MK, KJELLSTRAND PTT, BOBERG UC: Toxicity of peritoneal dialysis fluids on cultured fibroblasts, L-929. Kidney Int 40:77-79, 1991
43. TOPLEY N, COLES GA, WILLIAMS JD: Biocompatibility studies on peritoneal cells. Perit Dial Int 14:S21-S28, 1994
44. FRACASSO A, CALO L, BAZZATO G, BORSATTI A: Peritoneal sclerosis: Role of plasticizers in stimulating cytochines production. (abstract) J Am Soc Nephrol 4:404, 1993
45. DINARELLO CA, KRUEGER JM: Induction of interleukin 1 by synthetic naturally occurring muramyl peptides. Fed Proc 45:2545-2548, 1986
46. YOUNG GA, KENDALL S, BROWNJOHN AM: Complement activation during CAPD. Nephrol Dial Transplant 8:1372-1375, 1993